GILD vs VTAK · P/E 18, rev $7.80B vs rev $1.5M
Gilead Sciences Inc (GILD) versus Catheter Precision Inc. (VTAK) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Catheter Precision Inc. (VTAK) is a medical devices company listed on US.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported VTAK revenue for 2026-06-30 was $1.5M. Net income was -$5.0M. VTAK currently screens at market cap $3.0M.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. VTAK currently screens at market cap $3.0M.
Not investment advice. Open the GILD and VTAK stock pages for the full models.
Not investment advice.